Journal Mobile Options
Table of Contents
Vol. 16, No. 2, 1999
Issue release date: May 1999
Exp Clin Immunogenet 1999;16:98–106

Characterisation of the Human Central MHC Gene, BAT1: Genomic Structure and Expression

Allcock R.J.N. · Price P. · Gaudieri S. · Leelayuwat C. · Witt C.S. · Dawkins R.L.
aCentre for Molecular Immunology and Instrumentation, University of Western Australia, and bDepartment of Clinical Immunology, Royal Perth Hospital, Perth, Australia

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The BAT1 gene (D6S81E) encodes a member of the DEAD-box family of RNA-binding proteins, and lies in the central MHC. This region contains genes which affect susceptibility to immunopathological diseases. A 14-kb section of the human MHC containing the BAT1 gene and a further 5-kb telomeric of BAT1 was sequenced using DNA from individuals homozygous for HLA-A1, B8, DR3 and HLA- A1, B57, DR7. Analysis of our sequences and the previously reported human cDNA sequence showed that the expressed sequence of the 8.1 and 57.1 haplotypes is identical with only minor substitutions in the introns. Phylogenetic analysis suggests BAT1 may be a translation initiation factor. Screening of cells and tissues for BAT1 mRNA suggests an abundant member of a family of proteins expressed in multiple cell types, notably macrophages and hepatocytes. Expression was independent of MHC haplotype, consistent with the lack of sequence polymorphism.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL: Ancestral haplotypes: Conserved population MHC haplotypes. Hum Immunol 1992;34:242–252.
  2. Tait BD, Harrison LC: Overview: The major histocompatibility complex and insulin dependent diabetes mellitus; in Harrison LC, Tait BD: Clinical Endocrinology and Metabolism. London, Baillière Tindall, 1991, pp 211–228.
  3. McNeil AJ, Yap PL, Gore SM, Brettle RP, McColl M, Wyld R, Davidson S, Weightman R, Richardson AM, Robertson JR: Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Q J Med 1996;89:177–185.
  4. Green JR, Montasser M, Woodrow JC: The association of HLA-linked genes with systemic lupus erythematosus. Ann Hum Genet 1986;50:93–96.

    External Resources

  5. Degli-Esposti M, Chiewsilp P, Boongird P, Visudhiphan P, Chan SH, Tan CB, Illeni MT, Pellegris G, Bach JF, Caillat-Zucman S, Moriuchi J, Arimori S, Mehra NK, Dawkins RL: Myasthenia gravis; in Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991. New York, Oxford University Press, 1992, vol 1, pp 761–764.
  6. Alper CA, Fleischnick E, Awdeh ZL, Katz AJ, Yunis EJ: Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest 1987;79:251–256.
  7. French MAH, Townend D, Dawkins RL: Central major histocompatibility complex genes and IgA deficiency; in Chapel HM, Levinsky RJ, Webster ADB: Progress in Immune Deficiency III. London, Royal Society of Medicine Services, 1991, pp 31–36.
  8. Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW: Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. J Invest Dermatol 1995;104:856–858.
  9. Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL: Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 1992;36:345–356.

    External Resources

  10. Abraham LJ, French MAH, Dawkins RL: Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993;92:14–18.

    External Resources

  11. Brinkman BMN, Keet IPM, Miedema F, Verweij CL, Klein MR: Polymorphisms within the human tumour necrosis factor alpha promoter region in human immunodeficiency virus type 1-seropositive persons. J Infect Dis 1997;175:188–190.

    External Resources

  12. Hamman A, Mantzoros C, Vidal-Puig A, Flier JS: Genetic variability in the TNF alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995;211:833–839.
  13. Pociot F, D’Alfonso S, Scorza R, Richiardi PM: Functional analysis of a new polymorphism in the human TNF-alpha gene promoter. Scand J Immunol 1995;42:501–504.
  14. Shiina T, Tamiya G, Oka A, Yamagata T, Yamagata N, Kikkata E, Goto K, Mizuki N, Watanabe K, Fukuzumi Y, Taguchi S, Suguwara C, Ono A, Chen L, Yamazaki M, Tashiro H, Ando A, Ikemura T, Kimura M, Inoko H: Nucleotide sequencing of the 146-kilobase segment around the IkBL and MICA genes at the centromeric end of the HLA class I region. Genomics 1988;47:372–382.
  15. Gruen JR, Weissman SM: Evolving views of the major histocompatibility complex. Blood 1997;90:4252–4265.
  16. Spies T, Bresnahan M, Strominger JL: Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. Proc Natl Acad Sci USA 1989;86:8955–8958.
  17. Peelman L, Chardon P, Nunes M, Renard C, Geffrotin C, Vaiman M, Zeveren A, Coppieters W, Van de Weghe A, Bouquet Y, Choy W, Strominger J, Spies T: The BAT1 gene in the MHC encodes an evolutionary conserved putative nuclear RNA helicase of the DEAD family. Genomics 1995;26:210–218.
  18. Schmid SR, Linder P: D-E-A-D protein family of putative RNA helicases. Neurology 1992;47:1552–1555.
  19. Degli-Esposti MA, Leelayuwat C, Dawkins RL: Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: Possible relevance to autoimmune disease. Eur J Immunogenet 1992;19:121–127.

    External Resources

  20. Chan SH, Thai AC, Lin YN, Liu KF, Wee GB: Influence of gender and age at onset on the HLA associations in Chinese with insulin-dependent diabetes mellitus. Human Immunol 1995;44:175–180.

    External Resources

  21. Abraham LJ, Du DC, Zahedi K, Dawkins RL, Whitehead AS: Haplotypic polymorphisms of the TNFB gene. Immunogenetics 1991;33:50–53.
  22. Sambrook J, Fritsch EF, Maniatis T: 1. Molecular cloning: A laboratory manual. New York, Cold Spring Harbor Laboratory Press, 1989.
  23. Gaudieri S, Leelayuwat C, Townend D, Kulski J, Dawkins RL: Genomic characterization of the region between HLA-B and TNF: Implications for the evolution of multicopy gene families. J Mol Evol 1997;44:S147–S154.

    External Resources

  24. Leelayuwat C, Pinelli M, Dawkins RL: Clustering of diverse replicated sequences in the major histocompatibility complex (MHC): Evidence for en bloc duplication. J Immunol 1995;155:692–698.
  25. Nair S, Dey R, Sanford JP, Doyle D: Molecular cloning and analysis of an eIF-4A-related rat liver nuclear protein. J Biol Chem 1992;267:12928–12935.

    External Resources

  26. De Valoir T, Tucker MA, Belikoff EJ, Camp LA, Bolduc C, Beckingham K: A second maternally expressed Drosophila gene encodes a putative RNA helicase of the ‘DEAD box’ family. Proc Natl Acad Sci USA 1991;88:2113–2117.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50